Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges

Auteur(s): Annenberg Center for Health Sciences
  • Résumé

  • An indolent subtype of non-Hodgkin lymphoma, follicular lymphoma is characterized by eventual relapse of disease and the need for multiple lines of therapy, adding to the significant disease burden experienced by patients. Novel targeted agents in the relapsed/refractory setting have afforded new treatment options, but important clinical challenges exist, including optimal treatment sequencing, therapy evaluation and patient selection, transitions of care requirements, as well as toxicity management.
    Annenberg Center for Health Sciences
    Voir plus Voir moins
Épisodes
  • Solving Practice Challenges in Community-Based Interprofessional Care Teams
    Dec 14 2023

    In this 1-hour, online activity, lymphoma expert Jeremy Abramson, MD, shares his experience navigating these challenges as part of an interprofessional, multidisciplinary care team.

    Voir plus Voir moins
    50 min

Ce que les auditeurs disent de Current and Emerging Therapies for Follicular Lymphoma: Solving Practice Challenges

Moyenne des évaluations de clients

Évaluations – Cliquez sur les onglets pour changer la source des évaluations.